Singapore markets close in 6 hours 11 minutes
Straits Times Index
3,337.06 +5.36 (+0.16%) Nikkei
39,286.55 -380.52 (-0.96%) Hang Seng
17,769.44 -320.49 (-1.77%) FTSE 100
8,225.33 -22.46 (-0.27%) Bitcoin USD
60,907.05 -1,198.64 (-1.93%) CMC Crypto 200
1,267.07 -16.72 (-1.30%)
Gain Therapeutics, Inc. (GANX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.96M |
| Enterprise value | 20.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 255.50 |
| Price/book (mrq) | 3.70 |
| Enterprise value/revenue | 138.33 |
| Enterprise value/EBITDA | -1.55 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.48 |
| 52-week change 3 | -71.78% |
| S&P500 52-week change 3 | 24.60% |
| 52-week high 3 | 5.3300 |
| 52-week low 3 | 1.2000 |
| 50-day moving average 3 | 2.4484 |
| 200-day moving average 3 | 3.2015 |
Share statistics
| Avg vol (3-month) 3 | 219.27k |
| Avg vol (10-day) 3 | 749.19k |
| Shares outstanding 5 | 25.17M |
| Implied shares outstanding 6 | 25.17M |
| Float 8 | 16.83M |
| % held by insiders 1 | 6.76% |
| % held by institutions 1 | 11.07% |
| Shares short (31 May 2024) 4 | 80.5k |
| Short ratio (31 May 2024) 4 | 0.64 |
| Short % of float (31 May 2024) 4 | 0.48% |
| Short % of shares outstanding (31 May 2024) 4 | 0.45% |
| Shares short (prior month 30 Apr 2024) 4 | 154.19k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -74.54% |
| Return on equity (ttm) | -177.83% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.37M |
| Net income avi to common (ttm) | -21.14M |
| Diluted EPS (ttm) | -1.5000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.66M |
| Total cash per share (mrq) | 0.7 |
| Total debt (mrq) | 889.62k |
| Total debt/equity (mrq) | 10.29% |
| Current ratio (mrq) | 2.77 |
| Book value per share (mrq) | 0.48 |
Cash flow statement
| Operating cash flow (ttm) | -18.24M |
| Levered free cash flow (ttm) | -10.24M |
© 2024 Yahoo. All rights reserved.